REG - GSK PLC - Board Committee Change

GSKAnnouncement

08/03/2024 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240308:nRSH2295Ga&default-theme=true

RNS Number : 2295G  GSK PLC  08 March 2024

GSK plc

 

Board Committee Change

 

GSK plc today announces the following change to its Board Committee membership
with effect from 11 March 2024:

 

Dr Hal Dietz has been appointed a member of the Nominations & Corporate
Governance Committee. This appointment is in addition to his role as Chair of
the Science Committee and membership of the Chairs' Committee.

 

 

V A Whyte

Company Secretary

 

8 March 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAEAXDPEFELEFA